Skip Navigation

Cardiovascular Research 2005 67(4):636-646; doi:10.1016/j.cardiores.2005.05.006
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Maier, L. S.
Right arrow Articles by Pieske, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maier, L. S.
Right arrow Articles by Pieske, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats

Lars S. Maiera, Christian Wahl-Schottb,d, Wiebke Horna, Stefan Weicherta, Christian Pagela, Stefan Wagnera, Nataliya Dybkovaa, Oliver J. Müllerc, Michael Näbauerd, Wolfgang-M. Franzd,*,1 and Burkert Pieskea,1

aAbt. Kardiologie and Pneumologie/Herzzentrum, Georg-August-Universität Göttingen, Germany
bPharmakologie für Naturwissenschaften, Dept. Pharmazie, LMU München, Germany
cInnere Medizin III, Universitätsklinikum Heidelberg, Germany
dMed. Klinik and Poliklinik I-Großhadern, Marchioninistr. 15, 81377 München, Germany

* Corresponding author. Email address: wolfgang.franz{at}med.uni-muenchen.de

Received 7 January 2005; revised 18 April 2005; accepted 1 May 2005


    Abstract
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Objective: Heart failure is associated with reduced function of sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a) but increased function of sarcolemmal Na+/Ca2+ exchanger (NCX), leading to decreased SR Ca2+ content and loss of frequency-potentiation of contractile force. We reported that SERCA2a-overexpression in transgenic rat hearts (TG) results in improved contractility. However, it was not clear whether TG have improved contractility due to frequency-dependent improved SR Ca2+ handling.

Methods: Therefore, we characterized TG (n = 35) vs. wild-type (WT) control rats (n = 39) under physiological conditions (37 °C, stimulation rate <8 Hz). Twitch force, intracellular Ca2+ transients ([Ca2+]i), and SR Ca2+ content were measured in isolated muscles. The contribution of transsarcolemmal Ca2+ influx (ICa) through L-type Ca2+ channels (LTCC) and reverse mode NCX (INa/Ca) to Ca2+ cycling were studied in isolated myocytes.

Results: With increasing frequency, force increased in TG muscles by 168 ± 35% (8 Hz; P<0.05) and SR Ca2+ content increased by maximally 118 ± 31% (4 Hz; P<0.05). In WT, there was a flat force-frequency response without changes in SR Ca2+ content. Relaxation parameters of force and [Ca2+]i decay were accelerated at each frequency in TG vs. WT by ~10%. At prolonged rest intervals (<240 s), force and SR Ca2+ content increased significantly more in TG. Consequently, absolute SR Ca2+ content measured in myocytes was increased ~2-fold in TG. Transsarcolemmal Ca2+ fluxes estimated by ICa (at 0 mV –10.2 ± 1.1 vs. –16.9 ± 1.3 pA/pF) and INa/Ca (0.17 ± 0.02 vs. 0.46 ± 0.05 pA/pF) were decreased in TG vs. WT (P<0.05), whereas NCX and LTCC protein expression was only slightly reduced (P = n.s.).

Conclusion: In summary, SERCA2a-overexpression improved contractility in a frequency-dependent way due to increased SR Ca2+ loading whereas transsarcolemmal Ca2+ fluxes were decreased.

KEYWORDS Calcium (cellular); Contractile function; E–C coupling; Transgenic animal models; SR (function)


This article is referred to in the Editorial by J.W.M. Bassani and R.A. Bassani (pages 581–582) in this issue.


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Intracellular Ca2+ homeostasis and excitation–contraction (E–C) coupling are mainly regulated by the sarcoplasmic reticulum (SR): upon stimulation, Ca2+ enters the cells through L-type Ca2+ channels (LTCC), thereby inducing SR Ca2+ release and leading to contraction [1,2]. Ca2+ is eliminated from the cytosol by SR Ca2+-ATPase (SERCA2a) and to a smaller extent by sarcolemmal Na+/Ca exchanger (NCX). Under steady-state conditions, the same amount of Ca2+ as had been previously released from the SR is taken up by SERCA2a, while NCX extrudes that amount of Ca2+ that had previously entered the cell through LTCC [3]. Sarcolemmal Ca2+ pumps and mitochondrial Ca2+ uniporter eliminate only a small fraction of Ca2+ ions (1–2%) and may be more important in long-term Ca2+ regulation [2].

Contractile dysfunction in heart failure (HF) [4,5] was related to defective SR Ca2+ uptake in animal models [6] and humans [1]. Direct relationships between impaired force-frequency relation (FFR), intracellular Ca2+ transients ([Ca2+]i) [7,8], SR Ca2+ content [9,10], and SERCA2a expression [11] were reported in human HF. SERCA2a appears to play a key role for Ca2+ homeostasis, but little information regarding subcellular consequences of SERCA2a-overexpression is available.

Previous studies with SERCA2a-overexpressing transgenic mice [12,13], adenovirus-mediated gene transfer in neonatal rat myocytes [14,15], and animal models of HF reported enhanced contractility [16–18]. However, these studies investigated contractility under baseline conditions (force, shortening, ventricular pressure at low stimulation rates) but neither isometric twitch force nor SR Ca2+ content under the most physiological experimental conditions possible (37 °C) at increasing stimulation frequencies (up to 8 Hz). No detailed quantitative electrophysiological analyses of SR Ca2+ content, L-type Ca2+ currents (ICa), and NCX function (INa/Ca) were performed, and the effects of transgenic upregulation of SERCA2a on the expression and function of other Ca2+ regulatory proteins is completely unknown. Excessive SERCA2a-overexpression may even decrease contractility due to immediate Ca2+ reuptake before troponin C binding can occur ("futile" Ca2+ cycling) [19].

We recently reported that transgenic SERCA2a-overexpression in rat hearts (TG) leads to improved relaxation and contractility under normal and pressure overload conditions [20]. The aim of the present study was a detailed analysis of the effects of TG on E–C coupling processes under physiological conditions. Here, we demonstrate improved frequency-potentiation of force related to increased SR Ca2+ loading whereas transsarcolemmal Ca2+ cycling is reduced.


    2. Methods
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Ca2+ handling was investigated using TG (n = 35) and age-matched wild-type (WT) rats (n = 39) from one strain generated as reported recently [20]. SERCA2a protein level was overexpressed by 45.8 ± 6.1% in TG vs. WT. Data on heart and body weights did not differ between groups (Table 1a). The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US NIH (Publication No. 85-23, revised 1996). Experiments were performed in isolated left (n = 39) and right (n = 6) ventricular trabeculae or papillary muscles obtained from 17 WT and 28 TG rat hearts.


View this table:
[in this window]
[in a new window]

 
Table 1a Body weight, heart weight, muscle, and myocyte parameters

 

    2.1. RCC experiments
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Muscles were mounted into a chamber, superfused with Krebs-Henseleit-buffer (KHB) containing (in mmol/L): NaCl 127, KCl 2.3, NaHCO3 25, KH2PO4 1.3, MgSO4 0.6, CaCl2 1.5, glucose 11, insulin 10 IU/L (37 °C), and electrically stimulated. In order to measure SR Ca2+ loading, rapid cooling contractures (RCCs) were elicited by a decrease in chamber temperature to 1 °C [10,21].


    2.2. Intracellular Ca2+ transients
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Ca2+ transients were assessed using aequorin which was injected into the muscles [8]. Aequorin light emission was analyzed using the amplitude (mV amplifier output) and time course of signals. Since aequorin is consumed when Ca2+ is bound we do not calibrate our signals.


    2.3. Experimental protocol
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
FFR were tested by increasing frequency from 0.5–8 Hz. At each frequency recordings of isometric force were obtained followed by RCCs. In order to investigate the extent of which the SR gains Ca2+ during rest, rest intervals between 1–240 s were instituted from a basal frequency of 1 Hz and post-rest force or RCCs were measured. RCCs were normalized to basal values (0.5 Hz and 1 s rest, respectively) and only compared within each group. In a subset of experiments, isoproterenol (10–9–10–5 mol/L) was added to the solutions.


    2.4. Myocyte isolation
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Hearts were removed and perfused with a Tyrode's solution containing (in mmol/L): NaCl 138, KCl 4, MgCl2 1, glucose 10, NaH2PO4 0.33, HEPES 10 (37 °C), to which collagenase (70 mg/50 mL) and protease (6 mg/50 mL) were added for myocyte isolation [22].


    2.5. Recording techniques for patch-clamp experiments
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Experiments were carried out with microelectrodes having resistances of 2–3 M{Omega} (37 °C). Cell capacitance was calculated by applying 5 mV steps from –80 mV in the hyperpolarizing direction and integrating the current required to charge the membrane when stepping back to –80 mV.


    2.6. SR Ca2+ content
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Absolute SR Ca2+ content was determined by measuring the integral of caffeine-induced inward INa/Ca. Myocytes were held at –80 mV with an electrode containing (mmol/L): NaCl 5, CsCl 110, tetraethylammonium chloride (TEA) 20, MgCl2 1, MgATP 2, HEPES 10, EGTA 0.05. The cell was superfused in a microstream containing (mmol/L): NaCl 135, MgCl2 1, CaCl2 2, CsCl 10, glucose 10, HEPES 10. After a sequence of conditioning pulses (eight 200 ms pulses to 0 mV), followed by a 60 s rest to load the SR maximally with Ca2+, the cell was abruptly superfused for 6 s with caffeine (10 mmol/L) to release SR Ca. The resulting inward INa/Ca was integrated (nA*ms=pC) and normalized to cell volume (pC/pL) and capacitance (pC/pF).


    2.7. ICa
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Myocytes were superfused with solution containing (mmol/L): 135 NaCl, 10 CsCl, 1 MgCl2, 2 CaCl2, 10 glucose, and voltage-clamped [23] with an electrode filled with (mmol/L) 120 CsCl, 20 TEA, NaCl 1, MgCl2 1, EGTA 10, MgATP 2, HEPES 10. Myocytes were held at –80 mV and a prepulse to –45 mV inactivated Na+ channels. ICa was then activated by stepwise depolarizing from –30 to +80 mV (200 ms). Steady-state inactivation curves were determined by depolarizing the membrane (–60 to +60 mV) with conditioning pulses of 2 s, followed by a pulse to +10 mV. The current amplitudes during the second pulse were normalized to the maximal current amplitude, plotted as a function of the preceding membrane potential (Boltzmann function). Time constants of channel inactivation ({tau}1, {tau}2) were determined by biexponential function fitting the current evoked during a pulse to 0 mV.


    2.8. INa/Ca
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
For recordings of NCX activity, reverse-exchange current was measured. Myocytes were held at –40 mV. The pipette contained (mmol/L): CsCl 130, TEA 20, NaCl 20, MgCl2 1, EGTA 14, MgATP 2, HEPES 10, CaCl2 0.1. To activate outward currents, cells were superfused in a microstream containing (mmol/L): 145 NaCl, CsCl 10, 1 MgCl2, 2 CaCl2, 10 glucose, 10 HEPES. Outward exchange current was activated when the cell was immersed for 5 s in an adjacent microstream of solution containing Li+ instead of Na+.


    2.9. Western blots
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
For measuring protein expression of NCX and LTCC we performed standard Western blot techniques [11,19]. Briefly, equal amounts of protein were subjected to SDS-PAGE and blotted to nitrocellulose. The blots were blocked in 5% nonfat milk dissolved in TBS (20 mmol/L Tris–Cl, pH 7.5, 50 mmol/L NaCl), then probed with NCX antibodies (ABR), antibodies against the {alpha}1C subunit of LTCC (Alamone), or GAPDH (Bio Trend) in TBS containing 0.5% nonfat milk and 0.1% Tween 20. The membranes were incubated for 1 h with horse radish peroxidase-labeled antibody (Amersham). Immunoreactive bands were visualized and exposed to x-ray film.


    2.10. Statistics
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Data are expressed as mean ± S.E.M. Statistical analysis was performed with Student's unpaired t-test and one or two-way ANOVA followed by Student–Newman–Keuls test where appropriate. Statistical significance was taken as P<0.05.


    3. Results
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
3.1. Frequency-dependent effects on force and SR Ca2+ content
Fig. 1A shows representative isometric twitches and RCCs in muscles from WT and TG. When the muscles were rapidly cooled from 37 to 1 °C, Ca2+ was released from the SR and RCCs developed rapidly [2,24]. Twitch force marginally increased upon raising frequency in WT without changes in RCCs. In contrast, force and RCCs greatly increased in TG showing a frequency-dependent increase in SR Ca2+ load in TG but not WT.


Figure 1
View larger version (21K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 1 Frequency-dependent changes in twitch force and SR Ca2+ content. A. Representative isometric steady-state twitches and RCCs in muscles from a WT and a TG heart. B. Average values for twitch and RCC amplitudes in WT (n = 10) and TG (n = 20) muscles (%basal values at 0.5 Hz). *P<0.05 vs. 0.5 Hz, #P<0.05 WT vs. TG.

 
Average data for twitch force and RCCs in WT (Fig. 1B) did not change significantly when stimulation frequency was increased. In contrast, in TG force frequency-dependently increased by 168 ± 35% at 8 Hz (vs. 0.5 Hz; P<0.05). This positive FFR was accompanied by an increase in RCC amplitude by 88 ± 31% (P<0.05). Interestingly, absolute force values for twitches at 0.5 Hz did not differ significantly between WT and TG. However, increasing frequency to 8 Hz leads to higher force in TG compared to WT (Table 1b). It should be mentioned that WT rat myocardium usually shows a flat or only slightly positive FFR, and even negative FFR were reported [2,21,24].


View this table:
[in this window]
[in a new window]

 
Table 1b Force-frequency data

 
3.2. Increasing stimulation rate accelerates twitch contractions and Ca2+ transients
The time course of twitches and Ca2+ transients critically depends on SR Ca2+ uptake and is physiologically accelerated at high stimulation rates [2,25]. From typical twitch contractions and Ca2+ transients at 1 Hz (Fig. 2A) it can be seen that time to peak amplitudes is decreased, and relaxation and Ca2+ transient decline are shortened in TG. Fig. 2B shows average results for 50% and 90% relaxation of twitch force (RT50%, RT90%). At each frequency relaxation was faster by ~10% in TG compared to WT. RT50% decreased in WT from 35.1 ± 0.9 ms at 0.5 Hz to 26.4 ± 1.6 ms at 8 Hz (P<0.05), and in TG from 32.2 ± 0.6 to 25.1 ± 1.5 ms (P<0.05), and similarly in RT90%. In addition, values for 90% decay of Ca2+ transients are presented for WT and TG showing muscles with significant faster Ca2+ transient decay in TG at 0.5 Hz (44.0 ± 1.3 vs. 35.0 ± 1.1 ms, P<0.05) and 8 Hz (42.4 ± 1.1 vs. 30.8 ± 0.6 ms, P<0.05). Similarly, the time to peak tension and total twitch time decreased with increasing stimulation rates (Table 1b). Again, at all frequencies parameters were smaller in TG vs. WT.


Figure 2
View larger version (26K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 2 Influence of frequency on kinetics of twitches and Ca2+ transients. A. Normalized twitches and Ca2+ transients in muscles from a WT and TG heart (1 Hz). B. Average values for 50% and 90% relaxation (RT50%, RT90%) of force (WT n = 15, TG n = 19), and Ca2+ transients (inset: Aequorin RL90%; WT n = 5, TG n = 8) at increasing frequencies. *P<0.05 vs. 0.5 Hz, #P<0.05 WT vs. TG.

 
3.3. β-adrenergic stimulation increases force and accelerates Ca2+ transients
Fig. 3 summarizes the effects of β-adrenergic stimulation. TG and WT showed a concentration-dependent increase in force with isoproterenol (10–5 mol/L vs. control) with a maximum of 199 ± 50% for WT and 279 ± 75% for TG (P<0.05). This inotropic response is associated with typical acceleration of relaxation parameters of force as well as Ca2+ transient decay. RT90% in WT decreased from 70.3 ± 2.9 ms at control to 50.9 ± 2.5 ms with 10–5 mol/L isoproterenol (P<0.05), and in TG from 65.9 ± 2.6 to 43.4 ± 1.9 ms (P<0.05) with similar changes in RL90%. At each concentration of isoproterenol time parameters were shorter in TG vs. WT rats (by ~10%). These differences were even more pronounced at higher isoproterenol concentrations (~15%).


Figure 3
View larger version (23K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 3 Influence of isoproterenol on amplitude and kinetics of twitches and Ca2+ transients. Average values for twitch amplitude, RT90% of force (WT n = 15, TG n = 22), and Ca2+ transients (inset: Aequorin RL90%; WT n = 6, TG n = 6) when increasing isoproterenol concentration. *P<0.05 vs. 0.5 Hz. #P<0.05 WT vs. TG.

 
3.4. Increasing rest intervals raises SR Ca2+ content
Since RCCs are a semiquantitative measure of SR Ca2+ content, quantitative SR Ca2+ load was assessed using caffeine-induced inward INa/Ca [2]. Fig. 4A shows representative traces for INa/Ca with increased current in TG vs. WT. On average, INa/Ca was 4.98 ± 0.43 pA/pL in WT and increased in TG to 8.80 ± 2.07 pA/pL (P<0.05). The integrated charge transferred was also significantly higher in TG (8.13 ± 1.38 pC/pL or 1.28 ± 0.22 pC/pF) compared to WT (3.99 ± 0.28 pC/pL or 0.73 ± 0.05 pC/pF; P<0.05). When normalizing to cell volume, absolute SR Ca2+ load was 84.3 ± 14.3 in TG vs. 41.4 ± 2.9 µmol/L cytosol in WT (P<0.05). These results suggest that there is not only a frequency-dependent increase in SR Ca2+ load (as measured by RCCs), but also the absolute [Ca2+] in the SR is higher in TG.


Figure 4
View larger version (26K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 4 Effects on SR Ca2+content. A. Quantitative assessment of SR Ca2+ load measured as caffeine-induced inward INa/Ca in myocytes from WT (n = 10) and TG (n = 6) hearts. The inset shows the average SR Ca2+ load. *P<0.05 WT vs. TG. B. Average values for rest-dependent changes in twitch and RCC amplitudes in WT (n = 10) and TG (n = 10) muscles (%basal value 1 s rest). *P<0.05 vs. 1 s. #P<0.05 WT vs. TG.

 
We also analyzed the potential of the SR to accumulate Ca2+ during rest periods (Fig. 4B). Rats typically show potentiation of force after increasing rest intervals [2,21]. In WT, post-rest force increased by 126 ± 44% (P<0.05) after 240 s, but RCCs did not change. In contrast, TG showed much larger post-rest twitches at any rest interval (after 240 s by 198 ± 52%; P<0.05) associated with clear increases in RCCs (by 153 ± 55%; P<0.05). This suggests large rest-dependent SR Ca2+ accumulation in TG.

3.5. Decreased ICa and NCX function
Representative current–voltage relations show reduced current density at most voltages applied in TG vs. WT (Fig. 5A). Average data (Fig. 5B) depicts decreased peak ICa density at 0 mV of –10.2 ± 1.1 for TG vs. –16.9 ± 1.3 pA/pF for WT myocytes (P<0.05). However, Western blot analysis revealed no change in LTCC protein expression in TG (n = 10) vs. WT (n = 9) hearts (–3.8 ± 6.7%). Inactivation parameters did not differ between WT and TG (Table 2). However, there is a clear trend of faster ICa decline in TG which might be attributable to feedback through the increased SR Ca2+content in TG.


Figure 5
View larger version (19K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 5 Effects on L-type Ca2+ currents (ICa). A. Representative ICa in WT and TG myocytes when depolarizing stepwise from –30 to +80 mV. B. IV relation with average values for WT (n = 24) and TG (n = 6) myocytes. #P<0.05 WT vs. TG.

 

View this table:
[in this window]
[in a new window]

 
Table 2 ICa parameters

 
Representative traces for INa/Ca density measured by INa/Ca reverse mode were clearly reduced in TG compared to WT (Fig. 6A). Average data (Fig. 6B) show significantly lower INa/Ca outward current density in TG (0.17 ± 0.02 pA/pF) vs. WT (0.46 ± 0.05 pA/pF). This underlines that NCX function is reduced in TG vs. WT. Interestingly, we found only a slight reduction in NCX protein expression in TG (n = 10) vs. WT (n = 9) hearts of –12.0 ± 7.4%.


Figure 6
View larger version (12K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 6 A. Representative caffeine-induced outward INa/Ca. B. Average values for WT (n = 24) and TG (n = 6) myocytes. *P<0.05 WT vs. TG.

 

    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
This is the first detailed report on E–C coupling processes after transgenic SERCA2a-overexpression in rat myocardium under physiological conditions. Our main findings are that 1) a ~45% increase in SERCA2a protein levels is associated with improved contraction and relaxation kinetics and pronounced frequency or rest potentiation of force; 2) the functional effects were related to enhanced SR Ca2+ content and increased [Ca2+]i; and 3) ICa and NCX activity are reduced indicating a shift from transsarcolemmal to intracellular Ca2+ cycling.


    4.1. FFR and relaxation
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Depending on experimental conditions or strain, rat FFR can be negative, positive, or flat due to differences in SR Ca2+ handling [26,27]. In the present study, force and SR Ca2+ content in trabeculae of WT rats did not increase with increasing frequencies. This indicates that despite frequency-induced increases in ICa (due to increased frequency of action potentials) [2], the SR of WT rats is unable to respond to this extra amount of Ca2+ with enhanced SR Ca2+ load. This phenomenon was previously explained with the inability of WT rat heart to overcome the negative effects of refractoriness of SR Ca2+ release at high stimulation rates [24]. In contrast, in TG myocardium refractoriness can be easily overcome due to increased SR Ca2+ load resulting in a clear positive FFR. Most likely the increase in SR Ca2+ load is attributable to a frequency-dependent activation of SERCA2a (as previously shown by paired RCCs [10]), e.g. by CaMKII in combination with a decrease of Ca2+ extrusion via NCX (with less activity in TG) as a consequence of increased [Na+]i [28]. Another aspect is that phospholamban (PLB) expression is not altered in TG vs. WT [20]. Therefore, SERCA2a/PLB ratio is greatly increased with less PLB inhibiting SERCA2a leading to increased SR Ca2+ uptake in TG. Consequently, SERCA2a-overexpression leads to a greatly enhanced SR Ca2+ uptake and subsequent positive FFR.

Similarly, Hajjar et al. [29] reported for isolated rat myocytes that SERCA2a-overexpression can restore impaired FFR initially induced by PLB overexpression. The present data also agree with our observations in failing human myocardium that the FFR may be improved by low concentrations of forskolin [30] or isoproterenol [31]. However, stimulation of the cAMP–PKA axis not only stimulates SERCA2a activity by PLB phosphorylation, but has multiple further effects such as phosphorylation of LTCC, ryanodine receptors (RyR), or troponin C. Therefore, in our previous studies stimulation of the cAMP–PKA axis was far from normalizing contractility, and higher concentrations of forskolin or isoproterenol even had detrimental effects related to Ca2+ overload. In contrast, specific overexpression of SERCA2a protein selectively improves SR Ca2+ uptake [29].

It is important to note that the beneficial effect of SERCA2a-overexpression on contractility is most prominent at higher stimulation rates. This was previously only incompletely appreciated in muscles from transgenic mice at 22 °C which were stimulated up to 2 Hz [32]. Since our experiments in TG were performed at physiological temperature and frequencies (37 °C, up to 8 Hz), we believe that our results of a frequency-dependent increase in twitch force (and SR Ca2+ content) are of major importance for the understanding of the physiological consequences of SERCA2a-overexpression.

Twitch parameters at all frequencies were accelerated in TG rats. This observation can be explained by increased amounts of SERCA2a proteins in TG and CaMKII-dependent activation of SR Ca2+ uptake [33]. This effect was also observed in studies using PLB knockout mice [34] or SERCA2a transfected rabbit myocytes [35]. Intrinsic myofilament properties might also change relaxation kinetics [36].

β-adrenergic stimulation increases force and shortens activation and relaxation parameters of force and Ca2+ transients [37]. Similarly, in the present study force increased while relaxation parameters decreased. In addition, relaxation at each isoproterenol concentration was accelerated in TG vs. WT and increased concentration-dependently (from ~10% to ~15%). Interestingly, RT90% at the highest isoproterenol concentration was faster as compared to the relaxation at the highest stimulation frequency. Similar results were recently shown in SERCA2a transfected rabbit myocytes [38].


    4.2. SR Ca2+content
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
During rest Ca2+ is removed from the cytosol into the SR by SERCA2a and across the sarcolemma mainly by NCX [2]. There is a finite rate of SR Ca2+ leak which can either be taken up by the SR (resulting in constant SR Ca2+ load) or it can be partly removed from the cytosol by NCX (decreasing SR Ca2+ content). In the absence of SR Ca2+depletion rest potentiation of twitches appears to be normal in rat myocardium. This has been interpreted as a recovery of E–C coupling mechanism from a refractory state with increased fractional SR Ca2+ release [39,40].

The current results indicate that WT rat myocardium shows some increase in post-rest force associated with a marginal increased SR Ca2+ content. It appears that this rest potentiation of force is due to a very slow phase of recovery of SR Ca2+ release processes from a previous activation. This may be related to a slow phase of RyR recovery of normal Ca2+ sensitivity from an adapted or inactivated state and has been observed at the level of Ca2+ spark availability in rat and rabbit myocytes [2]. In contrast, TG is characterized by pronounced increases in post-rest force associated with marked increases in SR Ca2+ content and release. The reason for increased SR Ca2+ content during rest remains controversial. One reason could be that the SR content increases Ca2+ by means of decreased Ca2+ efflux via NCX [2]. While a slightly higher intracellular [Na+] in the cells from TG rats (even by 1 mM) could also explain this in principle, there is no evidence indicating that this is the case. Nevertheless, increased SERCA2a protein expression results in more effective SR Ca2+ reloading during rest. Similarly we could recently show that positive inotropic compounds which stimulate SERCA2a can improve the impaired post-rest behavior in failing human myocardium [31].

To supplement the semiquantitative RCC results with more quantitative analysis we quantified SR Ca2+ load by patch-clamp experiments. We confirmed that SR Ca2+ load in TG vs. WT is ~2-fold increased. This is in agreement with previous findings in SERCA2a transgenic mice [41]. However, the difference in SR Ca2+ load reported by these authors between TG vs. WT (~25%) was much smaller to our study. The most important differences between the two studies may be the different levels of SERCA2a-overexpression (20% vs. 46% in our study), the experimental conditions, as well as species. Yao et al. [41] used SERCA2a transgenic mice and measured at low temperature (25 °C) and low [Ca2+]o (1 mmol/L). In the present experiments we used myocytes from SERCA2a transgenic rats at 37 °C and [Ca2+]o of 2 mmol/L.

As a limitation of the study, it should be pointed out that the total amount of Ca2+ extruded by the NCX even might underestimate SR Ca2+ content since Ca2+ removal by sarcolemmal Ca2+ pumps and mitochondrial Ca2+ uptake were not taken into account [2]. Unfortunately, we do not have any information about these pathways in TG. Of note, decreased NCX activity measured in TG (although integral INa/Ca to assess SR Ca2+ load was used) might contribute to a possible underestimated SR Ca2+ content. Thus, NCX current measurements are qualitative in nature and may not always exactly reflect quantitative changes. Finally, a contribution of Ca2+ activated Cl currents and non-selective cation currents cannot be ruled out. However, when applying nickel to block NCX the current was completely abolished. Moreover, since no differences in these currents are expected to occur in TG vs. WT we do not believe that this has an impact on our main conclusions.


    4.3. ICa and NCX
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
It was previously reported that ICa was unchanged in TG vs. WT mice, whereas INa/Ca was decreased by ~10% [41]. We suggest in the present report that INa/Ca is reduced even ~2.5-fold and ICa by ~40% in TG vs. WT rats. As discussed in the previous section, these discrepancies may be due to differences in animal models and experimental conditions. However, these data also demonstrate that even in rat myocardium where Ca2+ cycling already in WT predominantly depends on SR Ca2+ transport [2], SERCA2a-overexpression further enhances intracellular vs. transsarcolemmal Ca2+ cycling.

When measuring Ca2+ influx and efflux and comparing these data we found very similar values. Not surprisingly to us, when calculating absolute values we found that ICa (Ca2+ influx) was 17.4 µmol/L for WT and 7.3 µmol/L for TG, i.e. the amount of Ca2+ entering the cell in TG via LTCC was only 42% compared to WT. Given the balance of fluxes, Ca2+ efflux via NCX should meet Ca2+ entry via LTCC. Indeed, when NCX outward current density (INa/Ca) was measured, there was a reduction of the transport capacity to 37% in TG vs. WT. Although not measured during regular E–C coupling, the latter result suggests the NCX activity seems to be reduced to a very similar amount as compared to the reduced ICa. In consequence, in the light of unchanged protein expression for NCX and LTCC, functional data shows reduced transsarcolemmal Ca2+ cycling vs. SR function. Nevertheless, further investigations in the presence of a functional SR are needed to fully understand the consequences of SERCA2a-overexpression.

Interestingly, there are striking similarities between our study (decreased ICa and increased SR Ca2+ content) and a study by Henderson et al. [42] who showed a 50% reduction in ICa in NCX-knockout mice. It may be that the same general phenomenology is occurring in our TG rats. Specifically, increased SR Ca2+ loads will lead to reduced ICa without changes in LTCC expression (as also shown by Henderson et al.). One potential mechanism for these observations might be via Ca2+ mediated inactivation of LTCC (i.e. faster Ca2+ efflux from the SR might promote rapid ICa inactivation). However, neither in our study nor in their study differences in inactivation kinetics were found (although we saw an almost significant trend with faster kinetics in TG vs. WT). Most likely, Ca2+ induced inactivation from increased SR Ca2+ release in TG does play a role. However, Henderson et al. speculated that the cells rather limit Ca2+ influx than upregulate Ca2+ efflux. Increased cytosolic/SR Ca2+ cycling might activate Ca2+ dependent transcription pathways leading to synthesis of non-functional channel protein as a means of protection from Ca2+ overload. However since this is completely speculative the unknown mechanisms of ICa and INa/Ca reduction are a limitation of the present study.


    4.4. Clinical relevance for HF
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
SERCA2a-overexpression might be useful in human HF [43] especially in patients with a negative FFR or diastolic dysfunction due to cytosolic Ca2+ overload. Because disturbed Ca2+ handling seems to play a role in the pathophysiology of HF, the relevance of SERCA2a-overexpression to rescue disturbed Ca2+ cycling and myocardial function is of particular importance. As shown by del Monte et al. [44] gene transfer of SERCA2a can improve contractility and can restore the impaired FFR in myocytes from failing human hearts. Nevertheless, further experimental work will be necessary to investigate the effects of SERCA2a-overexpression in transgenic animal models and SERCA2a gene transfer in human cardiac tissue on Ca2+ handling and myocardial performance.

However, an increased amount of SR Ca2+ may also be detrimental due to an increased potential for Ca2+ leak through RyR, potentially resulting in delayed afterdepolarizations and arrhythmias. This is even more important in HF where RyR may be hyperphosphorylated [33,45]. Indeed, we found increased mortality of SERCA2a TG rats after myocardial infarction, as reported recently by our group [46]. Therefore, SERCA2a-overexpression may improve Ca2+ handling but also induce arrhythmias under certain conditions. Future therapeutic approaches in HF may therefore be targeted to both improved SR Ca2+ uptake and stabilization of RyR.

In summary, whether and to what extent overexpressing SERCA2a might be beneficial in the treatment of HF has to be further investigated, since recent reports by Teucher et al. [19] and Chen et al. [46] in contrast to earlier work [12–18] showed negative effects on E–C coupling and increased arrhythmias under certain conditions.


    Acknowledgments
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 
Dr. Franz (SFB320/B-6) and Dr. Pieske are supported by DFG grants (PI414/2). Dr. Pieske is also supported by BMBFT (KHN-TP8). Dr. Wahl-Schott was supported by FoFöLe grant from LMU. Dr. Maier is supported by DFG Emmy-Noether-Programm (MA1982/1–2 and 1–4), by GlaxoSmithKline Research Foundation and by a grant from the Medizinische Fakultät (Forschungsförderung).


    Notes
 
1 Equal contribution. Back

Time for primary review 24 days


    References
 Top
 Abstract
 1. Introduction
 2. Methods
 2.1. RCC experiments
 2.2. Intracellular Ca2+...
 2.3. Experimental protocol
 2.4. Myocyte isolation
 2.5. Recording techniques for...
 2.6. SR Ca2+ content
 2.7. ICa
 2.8. INa/Ca
 2.9. Western blots
 2.10. Statistics
 3. Results
 4. Discussion
 4.1. FFR and relaxation
 4.2. SR Ca2+content
 4.3. ICa and NCX
 4.4. Clinical relevance for...
 Acknowledgments
 References
 

  1. Hasenfuss G., Pieske B. Calcium-cycling in congestive heart failure. J Mol Cell Cardiol (2002) 34:951–969.[CrossRef][Web of Science][Medline]
  2. Bers D.M. Excitation–contraction coupling and cardiac contractile force, 2nd ed. (2001) Dordrecht: Kluwer Academic Publishers.
  3. Bers D.M. Cardiac excitation–contraction coupling. Nature (2002) 415:198–205.[CrossRef][Medline]
  4. Gwathmey J.K., Copelas L., MacKinnon R., Schoen F.J., Feldman M.D., Grossman W., et al. Abnormal intracellular Ca2+ handling in myocardium from patients with end-stage heart failure. Circ Res (1987) 61:70–76.[Abstract/Free Full Text]
  5. Hasenfuss G., Mulieri L.A., Leavitt B.J., Allen P.D., Haeberle J.R., Alpert N.R. Alteration of contractile function and excitation–contraction coupling in dilated cardiomyopathy. Circ Res (1992) 70:1225–1232.[Abstract/Free Full Text]
  6. Hasenfuss G. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res (1998) 39:60–76.[Abstract/Free Full Text]
  7. Beuckelmann D.L., Näbauer M., Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation (1992) 85:1046–1055.[Abstract/Free Full Text]
  8. Pieske B., Kretschmann B., Meyer M., Holubarsch C., Weirich J., Posival H., et al. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation (1995) 92:1169–1178.[Abstract/Free Full Text]
  9. Lindner M., Erdmann E., Beuckelmann D.J. Calcium-content of SR in isolated ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol (1998) 30:743–749.[CrossRef][Web of Science][Medline]
  10. Pieske B., Maier L.S., Bers D.M., Hasenfuss G. Ca2+-handling and SR Ca2+-content in isolated failing and nonfailing human myocardium. Circ Res (1999) 85:38–46.[Abstract/Free Full Text]
  11. Hasenfuss G., Reinecke H., Studer R., Meyer M., Pieske B., Holtz J., et al. Relation between myocardial function and expression of SR Ca2+-ATPase in failing and nonfailing human myocardium. Circ Res (1994) 75:434–442.[Abstract/Free Full Text]
  12. He H., Giordano F.J., Hilal-Dandan R., Choi D.J., Rockman H.A., McDonough P.M., et al. Overexpression of the rat SR Ca2+-ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest (1997) 100:380–389.[Web of Science][Medline]
  13. Baker D.L., Hashimoto K., Grupp I.L., Ji Y., Reed T., Loukianov E., et al. Targeted overexpression of the SR Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts. Circ Res (1998) 83:1205–1214.[Abstract/Free Full Text]
  14. Hajjar R.J., Kang J.X., Gwathmey J.K., Rosenzweig A. Physiological effects of adenoviral gene transfer of SR Ca2+ATPase in isolated rat myocytes. Circulation (1997) 95:423–429.[Abstract/Free Full Text]
  15. Giordano F.J., He H., McDonough P., Meyer M., Sayen M.R., Dillmann W.H. Adenovirus-mediated gene transfer reconstitutes depressed SR Ca2+-ATPase levels and shortens prolonged cardiac myocyte Ca2+-transients. Circulation (1997) 96:400–403.[Abstract/Free Full Text]
  16. Miyamoto M.I., del Monte F., Schmidt U., DiSalvo T.S., Kang Z.B., Matsui T., et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci (2000) 97:793–798.[Abstract/Free Full Text]
  17. Schmidt U., del Monte F., Miyamoto M.I., Matsui T., Gwathmey J.K., Rosenzweig A., et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of SR Ca2+-ATPase. Circulation (2000) 101:790–796.[Abstract/Free Full Text]
  18. del Monte F., Williams E., Lebeche D., Schmidt U., Rosenzweig A., Gwathmey J.K., et al. Improvement in survival and cardiac metabolism after gene transfer of SR Ca2+-ATPase in a rat model of heart failure. Circulation (2001) 104:1424–1429.[Abstract/Free Full Text]
  19. Teucher N., Prestle J., Seidler T., Currie S., Elliott E.B., Reynolds D.F., et al. Excessive SERCA expression causes increased SR Ca2+-uptake but decreases myocyte shortening. Circulation (2004) 110:3553–3559.[Abstract/Free Full Text]
  20. Müller O.J., Lange M., Rattunde H., Lorenzen H.P., Müller M., Frey N., et al. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc Res (2003) 59:380–389.[Abstract/Free Full Text]
  21. Maier L.S., Brandes R., Pieske B., Bers D.M. Effects of left ventricular hypertrophy on force and Ca2+-handling in isolated rat myocardium. Am J Physiol (1998) 274:H1361–H1370.[Web of Science][Medline]
  22. Näbauer M., Beuckelmann D.J., Überfuhr P., Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation (1996) 93:168–177.[Abstract/Free Full Text]
  23. Yao A., Matsui H., Spitzer K.W., Bridge J.H., Barry W.H. SR and Na+/Ca-exchanger function during early and late relaxation in ventricular myocytes. Am J Physiol (1997) 273:H2765–H2767.[Web of Science][Medline]
  24. Maier L.S., Bers D.M., Pieske B. Differences in Ca2+-handling and SR Ca2+-content in isolated rat and rabbit myocardium. J Mol Cell Cardiol (2000) 32:2249–2258.[CrossRef][Web of Science][Medline]
  25. DeSantiago J., Maier L.S., Bers D.M. Frequency-dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban. J Mol Cell Cardiol (2002) 34:975–984.[CrossRef][Web of Science][Medline]
  26. Borzak S., Murphy S., Marsh J.D. Mechanisms of rate staircase in rat ventricular cells. Am J Physiol (1991) 260:H884–H892.[Web of Science][Medline]
  27. Layland J., Kentish J.C. Positive force- and [Ca2+]i-frequency relationships in rat ventriclular trabeculae at physiological frequencies. Am J Physiol (1999) 276:H9–H18.[Web of Science][Medline]
  28. Maier L.S., Pieske B., Allen D.G. Influence of stimulation frequency on [Na+]i and contractile function in Langendorff-perfused rat heart. Am J Physiol (1997) 273:H1246–H1254.[Web of Science][Medline]
  29. Hajjar R.J., Schmidt U., Kang J.X., Matsui T., Rosenzweig A. Adenoviral gene transfer of PLB in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of SR Ca2+-ATPase. Circ Res (1997) 81:145–153.[Abstract/Free Full Text]
  30. Pieske B., Trost S., Schütt K., Minami K., Just H., Hasenfuss G. Influence of forskolin on force-frequency behavior in nonfailing and end-stage failing human myocardium. Basic Res Cardiol (1998) 93(Suppl. 1):66–75.[CrossRef][Web of Science][Medline]
  31. Maier L.S., Schwan C., Schillinger W., Pieske B. Gingerol, isoproterenol, and ouabain normalize impaired post-rest behavior but not force-frequency relation in failing human myocardium. Cardiovasc Res (2000) 45:913–924.[Abstract/Free Full Text]
  32. Hashimoto K., Perez N.G., Kusuoka H., Baker D.L., Periasamy M., Marban E. Frequency-dependent changes in calcium cycling and contractile activation in SERCA2a transgenic mice. Basic Res Cardiol (2000) 95:144–151.[CrossRef][Web of Science][Medline]
  33. Maier L.S., Zhang T., Chen L., DeSantiago J., Brown J.H., Bers D.M. Transgenic CaMKII{delta}C-overexpression uniquely alters cardiac myocyte Ca2+-handling: reduced SR Ca2+-load and activated SR Ca2+-release. Circ Res (2003) 92:904–911.[Abstract/Free Full Text]
  34. Bluhm W.F., Kranias E.G., Dillmann W.H., Meyer M. Phospholamban: a major determinant of the cardiac force–frequency relationship. Am J Physiol (2000) 278:H249–H255.[Web of Science]
  35. Meyer M., Bluhm W.F., He H., Post S.R., Giordano F.J., Lew W.Y.W., et al. Phospholamban-to-SERCA2 ratio controls the force–frequency relationship. Am J Physiol (1999) 276:H779–H785.[Web of Science][Medline]
  36. Kassiri Z., Myers R., Kaprielian R., Banijamali H.S., Backx P.H. Rate-dependent changes of twitch force duration in rat cardiac trabeculae: a property of the contractile system. J Physiol (2000) 524:221–231.[Abstract/Free Full Text]
  37. Luo W., Grupp I.L., Harrer J., Ponniah S., Grupp G., Duffy J.J., et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res (1994) 75:401–409.[Abstract/Free Full Text]
  38. Chaudhri B., Del Monte F., Hajjar R.J., Harding S.E. Interaction between increased SERCA2a activity and β-adrenoceptor stimulation in adult rabbit myocytes. Am J Physiol (2002) 283:H2450–H2457.[Web of Science]
  39. Bassani R.A., Bers D.M. Na/Ca exchange is required for rest-decay but not for rest-potentiation of twitches in rabbit and rat ventricular myocytes. J Mol Cell Cardiol (1994) 26:1335–1347.[CrossRef][Web of Science][Medline]
  40. Bers D.M., Bassani R.A., Bassani J.W.M., Baudet S., Hryshko L.V. Paradoxical twitch potentiation after rest in cardiac muscle. J Mol Cell Cardiol (1993) 25:1047–1057.[CrossRef][Web of Science][Medline]
  41. Yao A., Su Z., Dillmann W.H., Barry W.H. SR function in murine ventricular myocytes overexpressing SR Ca2+ATPase. J Mol Cell Cardiol (1998) 30:2711–2718.[CrossRef][Web of Science][Medline]
  42. Henderson S.A., Goldhaber J.I., So J.M., Han T., Motter C., Ngo A., et al. Functional adult myocardium in the absence of Na+–Ca2+-exchange. Cardiac-specific knockout of NCX1. Circ Res (2004) 95:604–611.[Abstract/Free Full Text]
  43. Hasenfuss G. Calcium pump overexpression and myocardial function. Implications for gene therapy of myocardial failure. Circ Res (1998) 83:966–968.[Free Full Text]
  44. del Monte F., Harding S.E., Schmidt U., Matsui T., Kang Z.B., Dec G.W., et al. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation (1999) 100:2308–2311.[Abstract/Free Full Text]
  45. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell (2000) 101:365–376.[CrossRef][Web of Science][Medline]
  46. Chen Y., Escoubet B., Prunier F., Amour J., Simonides W.S., Vivien B., et al. Constitutive cardiac overexpression of SR Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias. Circulation (2004) 109:1898–1903.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. W.M. Bassani and R. A. Bassani
SERCA upregulation: Breaking the positive feedback in heart failure?
Cardiovasc Res, September 1, 2005; 67(4): 581 - 582.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Maier, L. S.
Right arrow Articles by Pieske, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maier, L. S.
Right arrow Articles by Pieske, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?